
Bernard Lipman
Examiner (ID: 17069)
| Most Active Art Unit | 1505 |
| Art Unit(s) | 1754, 1762, 1505, 1796, 1713, 3307 |
| Total Applications | 3506 |
| Issued Applications | 2903 |
| Pending Applications | 208 |
| Abandoned Applications | 395 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18326359
[patent_doc_number] => 20230124487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => A CONTROLLED DRUG RELEASE SYSTEM OF PHOTORESPONSIVE NANOCARRIERS, METHODS OF MAKING AND USING THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/904833
[patent_app_country] => US
[patent_app_date] => 2021-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17904833
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/904833 | Controlled drug release system of photoresponsive nanocarriers, methods of making and using thereof | Mar 16, 2021 | Issued |
Array
(
[id] => 16990092
[patent_doc_number] => 20210228512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => THERAPEUTIC COMPOUNDS, FORMULATIONS, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/203639
[patent_app_country] => US
[patent_app_date] => 2021-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21345
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17203639
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/203639 | Therapeutic compounds, formulations, and uses thereof | Mar 15, 2021 | Issued |
Array
(
[id] => 18365711
[patent_doc_number] => 20230147302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => PARTICLE SIZE CONTROL
[patent_app_type] => utility
[patent_app_number] => 17/910868
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8772
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17910868
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/910868 | PARTICLE SIZE CONTROL | Mar 11, 2021 | Abandoned |
Array
(
[id] => 17850546
[patent_doc_number] => 20220280587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => MEDICAL GELS CONTAINING A QUATERNARY AMMONIUM COMPOUND, PHENOXYETHANOL, ALOE VERA JUICE, AND NATURAL SPORICIDAL MOISTURIZERS
[patent_app_type] => utility
[patent_app_number] => 17/190628
[patent_app_country] => US
[patent_app_date] => 2021-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2795
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17190628
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/190628 | MEDICAL GELS CONTAINING A QUATERNARY AMMONIUM COMPOUND, PHENOXYETHANOL, ALOE VERA JUICE, AND NATURAL SPORICIDAL MOISTURIZERS | Mar 2, 2021 | Abandoned |
Array
(
[id] => 17080570
[patent_doc_number] => 20210275576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => MOLECULAR HYDROGEN-CONTAINING COMPOSITION FOR PREVENTION AND/OR IMPROVEMENT OF GENETIC DISORDER
[patent_app_type] => utility
[patent_app_number] => 17/189973
[patent_app_country] => US
[patent_app_date] => 2021-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3729
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17189973
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/189973 | MOLECULAR HYDROGEN-CONTAINING COMPOSITION FOR PREVENTION AND/OR IMPROVEMENT OF GENETIC DISORDER | Mar 1, 2021 | Abandoned |
Array
(
[id] => 16898929
[patent_doc_number] => 20210177845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => PDE9 INHIBITORS FOR TREATING SICKLE CELL DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/186442
[patent_app_country] => US
[patent_app_date] => 2021-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17652
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17186442
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/186442 | PDE9 inhibitors for treating sickle cell disease | Feb 25, 2021 | Issued |
Array
(
[id] => 17050554
[patent_doc_number] => 20210259988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => ELECTROSPUN STRUCTURES HAVING A PHARMACEUTICAL AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/181671
[patent_app_country] => US
[patent_app_date] => 2021-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10194
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17181671
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/181671 | ELECTROSPUN STRUCTURES HAVING A PHARMACEUTICAL AND METHODS OF MAKING AND USING THE SAME | Feb 21, 2021 | Abandoned |
Array
(
[id] => 16913776
[patent_doc_number] => 20210186868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => IMPLANTABLE DEPOTS FOR THE CONTROLLED RELEASE OF THERAPEUTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/248949
[patent_app_country] => US
[patent_app_date] => 2021-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44933
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17248949
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/248949 | Implantable depots for the controlled release of therapeutic agents | Feb 14, 2021 | Issued |
Array
(
[id] => 17034954
[patent_doc_number] => 20210251912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => Composition and Method for Transdermal Delivery of Cannabidiol (CBD) and 9-Tetrahydrocannabinol (THC)
[patent_app_type] => utility
[patent_app_number] => 17/170231
[patent_app_country] => US
[patent_app_date] => 2021-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17170231
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/170231 | Composition and method for transdermal delivery of cannabidiol (CBD) and D | Feb 7, 2021 | Issued |
Array
(
[id] => 17005536
[patent_doc_number] => 20210236697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => INJECTABLE COMPOSITE INKS AND METHODS FOR MAKING AND USING THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/150038
[patent_app_country] => US
[patent_app_date] => 2021-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14820
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17150038
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/150038 | Injectable composite inks and methods for making and using thereof | Jan 14, 2021 | Issued |
Array
(
[id] => 18194850
[patent_doc_number] => 20230048369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => POLYOXAZOLINE MODIFICATIONS MITIGATE STRUCTURAL DEGENERATION OF BIOPROSTHETIC HEART VALVES
[patent_app_type] => utility
[patent_app_number] => 17/792694
[patent_app_country] => US
[patent_app_date] => 2021-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7238
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17792694
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/792694 | POLYOXAZOLINE MODIFICATIONS MITIGATE STRUCTURAL DEGENERATION OF BIOPROSTHETIC HEART VALVES | Jan 12, 2021 | Pending |
Array
(
[id] => 20527224
[patent_doc_number] => 12545648
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-10
[patent_title] => Benzopyrazole compound
[patent_app_type] => utility
[patent_app_number] => 17/789662
[patent_app_country] => US
[patent_app_date] => 2020-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20098
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17789662
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/789662 | Benzopyrazole compound | Dec 29, 2020 | Issued |
Array
(
[id] => 17685687
[patent_doc_number] => 20220192979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => Liquid Micro-Dosing Product Containing an Effective Amount of Cannabis and Process for Making the Same
[patent_app_type] => utility
[patent_app_number] => 17/129519
[patent_app_country] => US
[patent_app_date] => 2020-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9057
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17129519
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/129519 | Liquid Micro-Dosing Product Containing an Effective Amount of Cannabis and Process for Making the Same | Dec 20, 2020 | Abandoned |
Array
(
[id] => 18167354
[patent_doc_number] => 20230033961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => COSMETIC COMPOSITION HAVING GLOSS AND LASTING PROPERTIES
[patent_app_type] => utility
[patent_app_number] => 17/787206
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17787206
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/787206 | COSMETIC COMPOSITION HAVING GLOSS AND LASTING PROPERTIES | Dec 17, 2020 | Pending |
Array
(
[id] => 18225733
[patent_doc_number] => 20230064727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => COMPOSITION FOR SKIN EXTERNAL APPLICATION
[patent_app_type] => utility
[patent_app_number] => 17/789363
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13319
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17789363
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/789363 | COMPOSITION FOR SKIN EXTERNAL APPLICATION | Dec 16, 2020 | Pending |
Array
(
[id] => 20370653
[patent_doc_number] => 12478063
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-25
[patent_title] => Nanosystems based on nanocomposites and natural extracts
[patent_app_type] => utility
[patent_app_number] => 18/257539
[patent_app_country] => US
[patent_app_date] => 2020-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 16
[patent_no_of_words] => 15325
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18257539
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/257539 | Nanosystems based on nanocomposites and natural extracts | Dec 13, 2020 | Issued |
Array
(
[id] => 18141151
[patent_doc_number] => 20230014993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => MINERAL SUPPLEMENTS FOR RUMINANT NUTRITION
[patent_app_type] => utility
[patent_app_number] => 17/784575
[patent_app_country] => US
[patent_app_date] => 2020-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5361
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17784575
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/784575 | Mineral supplements for ruminant nutrition | Dec 10, 2020 | Issued |
Array
(
[id] => 20491521
[patent_doc_number] => 12533376
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-27
[patent_title] => Prophylactic or therapeutic agent for disease induced by oxidative stress
[patent_app_type] => utility
[patent_app_number] => 17/113886
[patent_app_country] => US
[patent_app_date] => 2020-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 52
[patent_no_of_words] => 19360
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 200
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17113886
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/113886 | Prophylactic or therapeutic agent for disease induced by oxidative stress | Dec 6, 2020 | Issued |
Array
(
[id] => 17625861
[patent_doc_number] => 20220160876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => MACROMOLECULAR SYSTEM FOR DELIVERY OF EXOGENOUS ACTIVE SUBSTANCES WITH IMMUNE TRAP TO AVOID NEUTRALIZATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/104170
[patent_app_country] => US
[patent_app_date] => 2020-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3298
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17104170
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/104170 | MACROMOLECULAR SYSTEM FOR DELIVERY OF EXOGENOUS ACTIVE SUBSTANCES WITH IMMUNE TRAP TO AVOID NEUTRALIZATION THEREOF | Nov 24, 2020 | Abandoned |
Array
(
[id] => 16709967
[patent_doc_number] => 20210077114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => IMPLANTABLE DRUG ELUTING SYSTEM AND METHOD OF USE
[patent_app_type] => utility
[patent_app_number] => 17/102125
[patent_app_country] => US
[patent_app_date] => 2020-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8481
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17102125
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/102125 | IMPLANTABLE DRUG ELUTING SYSTEM AND METHOD OF USE | Nov 22, 2020 | Abandoned |